Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Anavex Life Sciences Corp. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- +7 vs. Q4 2025
- Shares held
- 40.0M
- +7.13M (+21.7%) vs. Q4 2025
- Total value
- $122.7M
- +$4.61M (+3.9%) vs. Q4 2025
- New holders
- 37
- 76 more added
- Sold out
- 30
- 46 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $95.8M |
| Q1 2026 | 190 | $122.7M |
| Q4 2025 | 186 | $136.1M |
| Q3 2025 | 186 | $289.3M |
| Q2 2025 | 178 | $301.9M |
| Q1 2025 | 181 | $269.2M |
| Q4 2024 | 169 | $316.5M |
| Q3 2024 | 145 | $153.2M |
| Q2 2024 | 141 | $113.3M |
| Q1 2024 | 147 | $161.3M |
| Q4 2023 | 153 | $240.8M |
| Q3 2023 | 143 | $164.1M |
| Q2 2023 | 144 | $205.6M |
| Q1 2023 | 141 | $232.3M |
| Q4 2022 | 139 | $248.7M |
| Q3 2022 | 148 | $251.4M |
| Q2 2022 | 150 | $249.4M |
| Q1 2022 | 139 | $308.2M |
| Q4 2021 | 149 | $383.2M |
| Q3 2021 | 136 | $370.1M |
| Q2 2021 | 127 | $492.2M |
| Q1 2021 | 108 | $271.9M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Anavex Life Sciences Corp.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −37,000−100.0% | Sold out |
| Deeter Investments LLP | 0 | $0 | 0.00% | −98,311−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −23,386−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −19,603−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −18,927−100.0% | Sold out |
| Saxon Interests, Inc. | 0 | $0 | 0.00% | −16,998−100.0% | Sold out |
| KLP Kapitalforvaltning AS | 0 | $0 | 0.00% | −16,400−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −13,261−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −12,412−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −6,036−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −3,710−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,626−100.0% | Sold out |
| Kohmann Bosshard Financial Services, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −1,321−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −481−100.0% | Sold out |
| American Wealth Advisors, LLC | 0 | $0 | 0.00% | −424−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −314−100.0% | Sold out |
| Turning Point Benefit Group, Inc. | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Pinnacle Wealth Planning Services, Inc. | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Thomasville National Bank | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |